ENTITY

Myriad Genetics (MYGN US)

10
Analysis
Health CareUnited States
Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
more
Company Event25 Feb 2026 05:00 • Upcoming
Add To Calendar
Company Event03 Dec 2025 01:00 • Latest
Company Event19 Nov 2025 02:20
Company Event04 Nov 2025 05:30
Company Event06 Aug 2025 04:30
x